Details for Patent: 8,748,459
✉ Email this page to a colleague
Summary for Patent: 8,748,459
| Title: | Pyridinoylpiperidines as 5-HT1F agonists |
| Abstract: | The present invention relates to compounds of formula I: or pharmaceutically acceptable acid addition salts thereof, where; The compounds of the present invention are useful for activating 5-HTlF receptors, inhibiting neuronal protein extravasation, and for the treatment or prevention of migraine in a mammal. The present invention also relates to a process for the synthesis of intermediates in the synthesis of compounds of Formula I. |
| Inventor(s): | Michael Philip Cohen, Daniel Timothy Kohlman, Sidney Xi Liang, Frantz Victor, Yao-Chang Xu, Bai-Ping Ying, DeAnna Piatt Zacherl, Deyi Zhang |
| Assignee: | Eli Lilly and Co |
| Application Number: | US13/363,895 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,748,459
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,748,459
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 039150 | ⤷ Start Trial | |||
| Austria | 341543 | ⤷ Start Trial | |||
| Australia | 2003224719 | ⤷ Start Trial | |||
| Brazil | 0308495 | ⤷ Start Trial | |||
| Brazil | PI0308495 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
